首页 | 本学科首页   官方微博 | 高级检索  
     

辛伐他汀对同型半胱氨酸诱导的人脐静脉内皮细胞的毒性和炎症反应的影响
引用本文:Hu YZ,Dong YG,Zhai YF,Lu JH,Wu MX,Zhou Y,He ZY. 辛伐他汀对同型半胱氨酸诱导的人脐静脉内皮细胞的毒性和炎症反应的影响[J]. 中华医学杂志, 2006, 86(32): 2297-2300
作者姓名:Hu YZ  Dong YG  Zhai YF  Lu JH  Wu MX  Zhou Y  He ZY
作者单位:1. 528300,广东省顺德第一人民医院心内科
2. 中山大学附属第一医院心内科
3. 公安部离退休干部局保健处
摘    要:目的探讨辛伐他汀对同型半胱氨酸(homocysteine,HCY)诱导的内皮细胞毒性和炎症的抑制作用。方法用不同浓度的HCY(0.1、0.25、0.5、1 mmol/L)处理人脐静脉内皮细胞24 h,采用四氮唑蓝检测细胞存活率;辛伐他汀(1、10、20μmol/L)预处理人脐静脉内皮细胞1 h,然后与HCY(0.25 mmol/L)共孵育,采用MTT检测细胞存活率,Western印迹和ELISA分析不同时间点相关炎性因子蛋白的表达。结果HCY处理后,人脐静脉内皮细胞存活率显著降低;而经过辛伐他汀(1、10、20μmol/L)预处理后,内皮细胞活性分别为47%±4%、68%±6%、89%±6%,明显高于单纯HCY(0.25 mmol/L)处理组(22%±3%,P均<0.01)。由HCY诱导的内皮细胞TNF-α、IL-6、MCP-1及ICAM-1的表达分别为0.23±0.05、0.14±0.03、0.13±0.04、0.21±0.07,与0 h时比较差异无统计学意义。结论辛伐他汀对同型半胱氨酸介导的内皮细胞损伤及炎症反应有明显的抑制作用。

关 键 词:高半胱氨酸 内皮细胞 炎性反应 辛伐他汀
收稿时间:2006-04-25
修稿时间:2006-04-25

Effects of simvastatin on homocysteine-induced endothelial dysfunction and inflammatory response
Hu Yun-zhao,Dong Yu-gang,Zhai Yu-feng,Lu Jian-hua,Wu Miao-xian,Zhou Yi,He Zong-yun. Effects of simvastatin on homocysteine-induced endothelial dysfunction and inflammatory response[J]. Zhonghua yi xue za zhi, 2006, 86(32): 2297-2300
Authors:Hu Yun-zhao  Dong Yu-gang  Zhai Yu-feng  Lu Jian-hua  Wu Miao-xian  Zhou Yi  He Zong-yun
Affiliation:Department of Cardiology, First People's Hospital of Shunde City, Shunde 528300, China.
Abstract:OBJECTIVE: To investigate the effects of simvastatin (SIM) on homocysteine (HCY)-induced endothelial dysfunction and inflammatory response. METHODS: Human umbilical vein endothelial cells (HUVECs) were isolated from the umbilical cords from healthy lying-in women and cultured and added with HCY of the concentrations of 0.1, 0.25, 0.5, and 1 mmol/L respectively, or HCY 0.25 mmol/L + SIM of the concentrations of 1, 10 and 20 micromol/L respectively for 1 hour. ELISA was used to detect the cell viability with MTT method. Western blotting was used to examine the protein expression of the cell inflammatory factors, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, macrophage chemoattractant protein (MCP)-1, and intercellular adhesion molecule (ICAM)-1, ELISA was used to detect the contents of the cell inflammatory factors. RESULTS: HCY of different doses inhibited the viability of HUVECs dose-dependently (all P < 0. 01). The survival rates of the HCY-induced HUVECs pretreatment by SIM of the concentrations of 1, 10 and 20 micromol/L for 1 hour were 1.72 +/- 0.03 times, 2.54 +/- 0.09 times, and 3.14 +/- 0.11 times respectively that of the control group (all P < 0. 01). HCY of different concentration of 0.25 mmol/L increased the protein expression of TNF-alpha, IL-6, MCP-1, and ICAM-1 significantly; however, the expression levels of TNF-alpha, IL-6, MCP-1, and ICAM-1 of the 0.25 mmol/L HCY-treated HUVECs that were pretreated by SIM of the concentration of 10 micromol/L for 1 hour were, 0.23 +/- 0.05, 0.14 +/- 0.03, 0.13 +/- 0.04, and 0.21 +/- 0.07 respectively, not significantly different from those at the time of 0 hour (all P > 0.05). CONCLUSION: Simvastatin inhibits the homocysteine-induced endothelial impairment and inflammatory response.
Keywords:Homocysteine   Endothelial cell   Inflammatory response   Simvastatin
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号